ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1453

Correlation between Clinical and Ultrasonographic Remission? the Effect of Non-Inflammatory Patient-Based Factors on Different Remission Definitions

Ummugulsum Gazel1, Sibel Yilmaz Oner2, Gulsen Ozen3, Yasemin Yalçınkaya3, Pamir Atagunduz3, Haner Direskeneli3 and Nevsun Inanc3, 1Rheumatology, Marmara University faculty of Medicine, Istanbul, Turkey, 2Rheumatology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey, 3Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: remission, rheumatoid arthritis (RA) and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II: Diagnosis and Prognosis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

In this study, we aimed to investigate the concordance of ultrasonographic remission with other remission criteria and to show the influence of non-inflammatory patient-induced factors such as depression, anxiety, fibromyalgia and fatigue on both clinical and ultrasonographic remission.

Methods:

Fifty consecutive patients with clinical remission (DAS-28-ESR <2.6) who were diagnosed according to the 2010 ACR / EULAR criteria were recruited to this study.

Patients were also assessed whether they met the Boolean and SDAI remission criteria. 28 joint gray scale (GS) and power Doppler (PD) ultrasonography were performed. Patients’ depression and anxiety were assessed by The Hospital Anxiety and Depression Scale (HADS), and their fatigue was assessed by multidimensional Assessment of Fatigue (MAF) scores and patients’ fibromyalgia was assessed by widespread pain index (WPI) and symptom severity score (SS).

Results:

Patients were divided into 4 groups according to different remission definitions by ultrasonography. (Group1: PD=0 and GS=0, Group2: PD=0 and GS≥0, Group3: PD=1 or 0 and GS=1 or 0, Group4: PD=1 or 0 and GS≥0).

Although it is not statistically significant, the highest agreement with all the clinical remission criteria was found in the USG remission group 4 (table).

Patients with ultrasonographic remissions at their first visit in 2011 were reevaluated with clinical remission criteria at the end of 5 years. The highest remission rates were found in patients with USG remission group 3 (DAS28 58%, Boolean 29%, SDAI 47%). There was no significant difference between fatigue, fibromyalgia, depression and anxiety measures between remission and non-remission in all USG remission groups. In contrast, depression (p <0.05) and anxiety (p <0.03) were significantly higher in patients without SDAI remission. Depression (p <0.008) and anxiety (p <0.014) were also significantly higher in patients without Boolean remission.

Conclusion:

Clinical and ultrasonographic remission was found to be compatible in half of the patients.

The compliance of the USG remission in Group 4 with the clinical remission definitions was good, and clinical remission continuity was higher in the group meeting the definition of group 3. In contrast the ultrasound remission, the high levels of depression and anxiety in patients without SDAI and Boolean remission suggest that non-inflammatory patient-derived measures have less influence on the ultrasound remission.

Table: The concordance between Ultrasound remission and other remission criteria

Das28 (n=50) SDAI (n=23) Boolean (n=22)
Group 1: PD=0 GS=0 n ( %) 13 (% 26) 8(%34,7) 5 (%22,7)
Group 2: PD=0 GS≥0 n ( %) 22 ( % 44) 10 (%43,4) 8(%36,3)
Group 3: PD=1 or 0 and GS=1 or 0 n ( %) 17 (%34) 8 (%34,7) 7 (%31,8)
Group 4: PD=1 or 0 and GS≥0 n ( %) 28 (%56) 13(%56,5) 11 (%50)

Disclosure: U. Gazel, None; S. Yilmaz Oner, None; G. Ozen, None; Y. Yalçınkaya, None; P. Atagunduz, None; H. Direskeneli, None; N. Inanc, None.

To cite this abstract in AMA style:

Gazel U, Yilmaz Oner S, Ozen G, Yalçınkaya Y, Atagunduz P, Direskeneli H, Inanc N. Correlation between Clinical and Ultrasonographic Remission? the Effect of Non-Inflammatory Patient-Based Factors on Different Remission Definitions [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/correlation-between-clinical-and-ultrasonographic-remission-the-effect-of-non-inflammatory-patient-based-factors-on-different-remission-definitions/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/correlation-between-clinical-and-ultrasonographic-remission-the-effect-of-non-inflammatory-patient-based-factors-on-different-remission-definitions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology